Elemental Analysis Market Worth $2.02 Billion By 2025 | CAGR: 6.2%: Grand View Research, Inc.


"Grand View Research, Inc. - Market Research And Consulting."
According to report published by Grand View Research,The global elemental analysis market size is projected to grow at a CAGR of 6.2% during the forecast period Due To Growing awareness due to conferences, meetings, and congresses.

The global elemental analysis market is expected to reach USD 2.02 billion by 2025, growing at a CAGR of 6.2%, according to a new report by Grand View Research, Inc. The market is primarily driven by amendments in the ICH (International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use) regulations that mandate use of elemental analysis for finished medical products, including pharmaceuticals.

Many manufacturers of elemental analyzers invest in R&D of new and technologically advanced products. In addition to their expenses for R&D, many key players launched new products in the market in the past 3 years. For instance, in May 2016, Agilent Technologies launched Agilent 5110 ICP-OES, which was designed to enable scientists perform fast and precise elemental analysis of pharmaceuticals and food products along with mining, industrial, and environmental analysis.

In addition, in many countries, the limit of heavy metals/trace elements is regulated by their respective pharmacopeias. For instance, United States, Japanese, and European pharmacopeias limit the amount of trace elements in finished pharmaceutical products. Furthermore, elemental analysis is a crucial step before commercial launch of a medical product in the market.

North America held the largest market share in 2016. Local presence of large number of manufacturers, regulation of limits of trace elements/heavy metals by United States Pharmacopeia (USP), and ongoing research for development of new products are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. Rise in interest of market players to expand their business in Asia Pacific, growing awareness on safety of pharmaceuticals, and increase in expenditure by local pharmaceutical companies on elemental analyzers are factors that can be attributed for the highest growth rate of Asia Pacific region during the forecast period.

Full Research Report On Elemental Analysis Market  Analysis: 
http://www.grandviewresearch.com/industry-analysis/elemental-analysis-market

U.S. elemental analysis market, by type of elements, 2014 - 2025 (USD Million)

U.S. elemental analysis market, by type of elements, 2014 - 2025 (USD Million)

 

Further Key Findings From the Report Suggest:

  • The inorganic elements segment held the largest revenue share in 2016 due upcoming mandates for elemental analysis in medical products

  • Nondestructive technologies held the largest revenue share of the market, by technology, in 2016. Retention of sample after analysis and high precision rate can be the key factors for largest share of this segment

  • North America dominated the global market due to presence of USP regulations that limit the amount of heavy metals/trace elements

  • Some of the key players arePerkinElmer, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; Shimadzu Corporation; and Analytik Jena AG; among others

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Elemental analysis market, by region, 2016 (%)

 

Elemental analysis market, by region, 2016 (%)

Grand View Research, Inc. has segmented the elemental analysis market on the basis of type of elements analyzed, technologies used, and region:

Elemental Analysis Type of Elements Outlook (Revenue, USD Million, 2014 - 2025)

  • Organic Elements

  • Inorganic Elements

Elemental Analysis Technology Outlook (Revenue, USD Million, 2014 - 2025)

  • Destructive Technologies

    • ICP-MS

    • ICP-OES

    • Combustion Analysis

    • Other destructive technologies

  • Nondestructive Technologies

    • XRF

    • FTIR

    • Other nondestructive technologies

Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

Access Full Press Of This Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-elemental-analysis-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: sales@grandviewresearch.com
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/elemental-analysis-market



Oxygen Enriched Membrane Market Is Expected To Reach Over US$ 1,300 Mn By 2025 – Acute Market Reports


"Acute Market Reports Logo"
Oxygen Enriched Membrane Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies And Forecasts, 2017 To 2025

Oxygen Enriched Membrane Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies And Forecasts, 2017 To 2025

Oxygen Enriched Membrane Market Growth, Future Prospects and Competitive Analysis, 2017 – 2025, the global oxygen enriched membrane market is expected to reach over US$ 1,300 Mn by 2025, expanding at a CAGR of 8.4% from 2017 to 2025.

View Full Report with TOC @ http://www.acutemarketreports.com/report/oxygen-enriched-membrane-market

Market Insights

Oxygen enriched membranes have gained an important place in chemical technology and are used in a broad range of applications. The global oxygen enriched membrane market is expected to reach US$ 1,300 Mn by 2025, expanding at a CAGR of 8.4% from 2017 to 2025.

On the basis of application, the global oxygen enriched membrane market is segmented into medical application, enhanced combustion, water treatment, and others. Among these, medical segment dominated the market and accounted for 45.83% share of the global market in 2015. This segment is projected to maintain its dominance over the next eight years. This market is primarily witnessing growth owing to increase in number of elderly and sick people which require oxygen-enriched air to facilitate smooth breathing.

For the purpose of this study, the global oxygen enriched membrane market is categorized into regional markets viz., North America, Europe, Asia Pacific and Latin America and Middle East and Africa. In base year 2015, North America was observed as the largest market for oxygen enriched membrane. Renewable fuel standards in U.S. and European Union creating a market for second generation bio-fuels, which will generate demand for oxygen enriched membrane for enhanced combustion. Asia Pacific and Latin America are sought after regional markets in terms of growth opportunities for upcoming years for oxygen enriched membrane. Asia Pacific is expected to achieve highest growth rate compared to other regions due to presence of countries such as China, India and Japan are observing significant industrial growth. Stricter regulations of water quality in economy like China and Japan will provide growth for oxygen enriched membrane from the region. Unmet medical needs generated from a rapidly ageing population, and increasing healthcare infrastructure spending across Asia Pacific and Latin America should act as a catalyst to the growth of oxygen enriched membrane.

Download Free Sample Report @ http://www.acutemarketreports.com/request-free-sample/108614

Furthermore, the companies are focusing on expanding their business network, across regional markets. They are strengthening their market penetration by offering wide product range in the oxygen enriched membrane segment. Due to relatively long lifetime of oxygen enriched membrane enabled systems, the need for new membrane is limited. Air Products and Chemicals Incorporated, Dalian Puricle Co., Ltd., GE Water & Process Technologies, Genrich Membranes Pvt. Ltd., Membrane Technology and Research, Inc., Pall Corporation, Parker Hannifin Corp., Teijin Pharma Limited, The Dow Chemical Company, Pacific Consolidated Industries, Sigma-Aldrich Co. LLC. (Merck Group), Atlas Copco AB, NOXERIOR S.r.l., Membrana GmbH (3M Company) and GENERON are few key manufacturers in oxygen enriched membranes market.

Key Trends:

• Oxygen enriched membrane market is witnessing growth due to rise in demand from various end uses
• The companies are focusing on enhancing their product portfolio across the key consuming regions
• Asia Pacific is expected to register the highest growth rate

View Full Report with TOC @ http://www.acutemarketreports.com/report/oxygen-enriched-membrane-market

About Us:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Latest Reports:

http://www.acutemarketreports.com/report/iot-platforms-for-telemedicine-market

http://www.acutemarketreports.com/report/pancreatic-cancer-diagnostics-using-artificial-intelligence-for-hospitals-market

Media Contact
Company Name: Acute Market Reports
Contact Person: Chris Paul
Email: sales@acutemarketreports.com
Phone: India: +91 7755981103, Toll Free US/Canada: +1-855-455-8662
Address:Office No 01, 1st Floor, Aditi Mall, Baner
City: Pune
State: Maharashtra
Country: India
Website: http://www.acutemarketreports.com/report/oxygen-enriched-membrane-market



Parry-Romberg Syndrome Market | Which is Expected Grow at a Steady CAGR Of ~7.8% | World Major Key Players Profile | Forecast to 2023


"rnParry-Romberg Syndrome Market"
Market Research Future has a half cooked research report on the global Parry Romberg syndrome market. Parry-Romberg Syndrome Market is Expected Grow at a Steady CAGR Of ~7.8% by 2023

According to the National Organization for Rare Disorder, Parry-Romberg syndrome is a rare and acquired disorder, which slowly shrink the skin and tissues of half of the face in most of the cases. In rare cases, both sides of the face are affected. In some cases, it may also affect the limbs usually on the same side of the body.

The global Parry-Romberg syndrome market is majorly driven by the increasing skin diseases patient population, increasing prevalence neurological disorders, and rapidly increasing demand for better diagnosis & treatment methods.

According to the Department of Economic and Social Affairs Population Division, globally, the number of adults aged over 60 years were 841 million in 2013, which increased the patient population of eye related diseases. Moreover, poor diet and lack of exercise have fuelled the prevalence of neurological disorders, which propels the market growth. However, high cost of the current treatment methods and lack of improved diagnosis methods may slow the growth of the market.

The global Parry-Romberg syndrome market is expected grow at a steady CAGR of ~7.8% during the forecasted period.

Taste the market data and market information presented through more than 125 market data tables and figures spread over 115 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Parry Romberg syndrome market research report–Global forecast till 2023.”

 Get a Sample report at https://www.marketresearchfuture.com/sample_request/4395 .

Major Players in the Parry-Romberg Syndrome Market

Some of the key players in the global market are DePuy Synthes (U.S.), Johnson & Johnson Services, Inc. (US), Medtronic (Ireland),Abbott (US), Immediate Media Company Ltd. (US), Taj Pharmaceuticals Ltd.,  Pfizer, Inc., Sanofi-Aventis, Biogen, Inc., GlaxoSmithKline, Inc., and AstraZeneca plc.

Regional Analysis

The global Parry Romberg syndrome market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

America accounts for the largest Parry-Romberg syndrome market owing to constantly increasing patient population of skin diseases, eye diseases, neurological disorder, and increasing government support for research.

Europe holds the second position in the market due to increasing development and more focus on healthcare domain. Countries such as Germany and France are investing more in research & development to develop new treatment methods for various skin diseases and eye disorder.    

Asia Pacific is expected to be the fastest growing region for Parry-Romberg syndrome market. Increasing geriatric population, rising healthcare expenditure, and increasing prevalence of skin diseases drives the growth of the market.  Moreover, developing countries such as India are focusing more on research & development by investing more in healthcare, which will boost the market growth.

On the other hand, the Middle East & Africa owns the least share of the Parry-Romberg syndrome market. The Middle East & Africa is expected witness the least market share due to less development in healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.

Segmentation

The global Parry-Romberg syndrome market is segmented on the basis of diagnosis, treatment, and end users.

On the basis of diagnosis, the market is segmented into physical examination, MRI, serum test, and other.

On the basis of treatment, the market is categorized into drug treatment, surgery, and others. Drug treatment is further segmented into methotrexate, corticosteroids, cyclophosphamide, and azathioprine, and other. Surgery segment is sub-segmented into orthognathic surgery, microsurgical reconstructive surgery, and others.

On the basis of end user, the market is segmented into hospitals & clinics, physical therapists, and others.

Get a discount at https://www.marketresearchfuture.com/check-discount/4395   

Europe accounts for the second largest Parry-Romberg syndrome market across the globe owing to increasing government support for research & development, and increasing investment in healthcare. The countries such as France, and Germany investing in the healthcare to develop new diagnosis and treatment methods for rare diseases, which will boost the market growth. As per Organization for Economic Co-operation and Development (OECD), the share of GDP to health spending in Germany was 11.0% in 2013, compared with a share of GDP was up from 10.8% in 2012, which is responsible for the growth of the market in this region.

Asia Pacific has the fastest growing market, increasing government support for research & development, increasing prevalence of skin diseases, eye related diseases, and huge population base and rapidly developing economy drives the growth of the market in this region. Developing countries in this region are focusing more in the development of healthcare domain for instance country such as India.

The Middle East & Africa is expected to show the least market share due to less availability of medical facilities, and less development in healthcare domain.

 Table Of Content    

1.    Report Prologue    

2.    Market Introduction    


      2.1    Definition    

      2.2    Scope Of The Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

Browse Complete Report at https://www.marketresearchfuture.com/reports/parry-romberg-syndrome-market-4395 .

3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary Research    

      3.4    Market Size Estimation

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/parry-romberg-syndrome-market-4395



The World Vaccine Adjuvants Industry is Projected to Grow at a CAGR of 10.1% by 2023


"Vaccine Adjuvants Market"
Market Research Future has a half cooked research report on the global vaccine adjuvants market. Vaccine Adjuvants Market is Expected to Grow at a CAGR of 10.1% by 2023

Adjuvant is a substance that enhance the immune responses against antigens. More than one adjuvant may be present in the final vaccine products. Aluminum salts, such as aluminum hydroxide, aluminum phosphate, and aluminum potassium sulfate are widely used as an adjuvant in the vaccines production. Increasing demand for adjuvants to enhance and extend immune response, and need for development of safe and non-toxic adjuvants will boost the growth of the market. Moreover, increasing use of synthetic vaccines and recombinant vaccines are also expected to drive the global vaccine adjuvants market over the forecast period. Moreover, increasing demand for improved and long-lasting vaccination against existing and emerging diseases and increasing vaccination programs by the government and research and development activities favor the growth of this market in this region. On the other hand, high toxicity of adjuvants, and high developing cost for a new vaccine adjuvants may hamper the growth of the market.

The global vaccine adjuvants market is expected to grow at a CAGR of 10.1% during the forecast period 2017-2023.

Taste the market data and market information presented through more than 105 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “vaccine adjuvants market research report–Global forecast till 2023.”

 Sample Report Available at https://www.marketresearchfuture.com/sample_request/1098 .

Major Players in Vaccine adjuvants Market

Some of the key players in the global market are VaxLiant LLC.(U.S),Vaxine Pty Ltd (Australia), Aphios Corporation (U.S), Viscogel AB (Sweden), Adjuvatis (France), Sergeant Adjuvants (U.S), Sigma-Aldrich Co. LLC.(India), CureVac AG (Germany), Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (Fracne), Agenus, Inc. (U.S), Novavax, Inc.(U.S), SPI Pharma, Inc.(U.S), Invivogen (U.S), Avanti Polar Lipids, Inc. (U.S), MPV Technologies (U.S), and  OZ Biosciences (France). 

Regional Analysis

The global vaccine adjuvants market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global market due to major initiatives taken by the government for vaccination against many diseases as well as excellent management of public awareness programs. Europe is the second largest market owing to increased emphasis and availability of funds for research and development. The government is campaigning about vaccination and various preventive measures against infectious and non-infectious diseases. Recently, governments in developing countries of Asia Pacific have undertaken various vaccinations programs to the educate people. India is expected to be an emerging and the fastest growing market due to increasing focus on immunization programs by various government and NGOs. The market shows steady growth in the Middle East & Africa due to lower demand for vaccine adjuvants as compared to other regions across the globe.

Segmentation

The global vaccine adjuvants are segmented by types, routes of administration, and end users. On the basis of types, it is segmented into pathogen components, particulate adjuvants, and others. On the basis of routes of administration, it is segmented into oral, intramuscular, subcutaneous, and intradermal. On the basis of end users, it is segmented into pediatric, adult.

 Browse complete report at https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098 . 

Vaccine adjuvant is an immunological agent that modifies the effect of other agents. It is added to vaccine in order to enhance the immune response and to provide long-lasting protection against antigen. Aluminum hydroxide and paraffin oil are most commonly used adjuvants. Governments’ initiatives for vaccinations, high prevalence of infectious and zoonotic diseases, and growing focus on improved and long-lasting immunization against existing and emerging diseases are major driving forces for the growth of the market. Moreover, increasing investments by companies in research and development, increasing focus on immunization programs, and increasing demand for vaccines are fueling to the market growth. Additionally, increasing prevalence of the diseases in children and rising number of awareness programs to promote vaccination are expected to drive the growth of this market over the forecast period. However, high toxicity of adjuvants, and cost of developing a new vaccine adjuvants may hamper the growth of the market. 

Table Of Contents

1    Report Prologue    

2    Market Introduction    


      2.1    Introduction    

      2.2    Scope Of Study    

      2.3    Research Objective    

      2.4    Assumptions & Limitations    

            2.4.1    Assumptions    

            2.4.2    Limitations    

3    Research Methodology    

      3.1    Research Process    

      3.2    Primary Research    

      3.3    Secondary Research    

4    Market Dynamics    

      4.1    Drivers    

      4.2    Restraints    

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098



The World Vaccine Adjuvants Industry is Projected to Grow at a CAGR of 10.1% by 2023


"Vaccine Adjuvants Market"
Market Research Future has a half cooked research report on the global vaccine adjuvants market. Vaccine Adjuvants Market is Expected to Grow at a CAGR of 10.1% by 2023

Adjuvant is a substance that enhance the immune responses against antigens. More than one adjuvant may be present in the final vaccine products. Aluminum salts, such as aluminum hydroxide, aluminum phosphate, and aluminum potassium sulfate are widely used as an adjuvant in the vaccines production. Increasing demand for adjuvants to enhance and extend immune response, and need for development of safe and non-toxic adjuvants will boost the growth of the market. Moreover, increasing use of synthetic vaccines and recombinant vaccines are also expected to drive the global vaccine adjuvants market over the forecast period. Moreover, increasing demand for improved and long-lasting vaccination against existing and emerging diseases and increasing vaccination programs by the government and research and development activities favor the growth of this market in this region. On the other hand, high toxicity of adjuvants, and high developing cost for a new vaccine adjuvants may hamper the growth of the market.

The global vaccine adjuvants market is expected to grow at a CAGR of 10.1% during the forecast period 2017-2023.

Taste the market data and market information presented through more than 105 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “vaccine adjuvants market research report–Global forecast till 2023.”

 Sample Report Available at https://www.marketresearchfuture.com/sample_request/1098 .

Major Players in Vaccine adjuvants Market

Some of the key players in the global market are VaxLiant LLC.(U.S),Vaxine Pty Ltd (Australia), Aphios Corporation (U.S), Viscogel AB (Sweden), Adjuvatis (France), Sergeant Adjuvants (U.S), Sigma-Aldrich Co. LLC.(India), CureVac AG (Germany), Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (Fracne), Agenus, Inc. (U.S), Novavax, Inc.(U.S), SPI Pharma, Inc.(U.S), Invivogen (U.S), Avanti Polar Lipids, Inc. (U.S), MPV Technologies (U.S), and  OZ Biosciences (France). 

Regional Analysis

The global vaccine adjuvants market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global market due to major initiatives taken by the government for vaccination against many diseases as well as excellent management of public awareness programs. Europe is the second largest market owing to increased emphasis and availability of funds for research and development. The government is campaigning about vaccination and various preventive measures against infectious and non-infectious diseases. Recently, governments in developing countries of Asia Pacific have undertaken various vaccinations programs to the educate people. India is expected to be an emerging and the fastest growing market due to increasing focus on immunization programs by various government and NGOs. The market shows steady growth in the Middle East & Africa due to lower demand for vaccine adjuvants as compared to other regions across the globe.

Segmentation

The global vaccine adjuvants are segmented by types, routes of administration, and end users. On the basis of types, it is segmented into pathogen components, particulate adjuvants, and others. On the basis of routes of administration, it is segmented into oral, intramuscular, subcutaneous, and intradermal. On the basis of end users, it is segmented into pediatric, adult.

 Browse complete report at https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098 . 

Vaccine adjuvant is an immunological agent that modifies the effect of other agents. It is added to vaccine in order to enhance the immune response and to provide long-lasting protection against antigen. Aluminum hydroxide and paraffin oil are most commonly used adjuvants. Governments’ initiatives for vaccinations, high prevalence of infectious and zoonotic diseases, and growing focus on improved and long-lasting immunization against existing and emerging diseases are major driving forces for the growth of the market. Moreover, increasing investments by companies in research and development, increasing focus on immunization programs, and increasing demand for vaccines are fueling to the market growth. Additionally, increasing prevalence of the diseases in children and rising number of awareness programs to promote vaccination are expected to drive the growth of this market over the forecast period. However, high toxicity of adjuvants, and cost of developing a new vaccine adjuvants may hamper the growth of the market. 

Table Of Contents

1    Report Prologue    

2    Market Introduction    


      2.1    Introduction    

      2.2    Scope Of Study    

      2.3    Research Objective    

      2.4    Assumptions & Limitations    

            2.4.1    Assumptions    

            2.4.2    Limitations    

3    Research Methodology    

      3.1    Research Process    

      3.2    Primary Research    

      3.3    Secondary Research    

4    Market Dynamics    

      4.1    Drivers    

      4.2    Restraints    

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098



ACOG Quietly changes Baby to Fetus in Patient Pregnancy Handout

MESA, ARIZONA - 24 Nov, 2017 - A very subtle word change in a widely distributed patient handout may have major political implications.  The American Congress of Obstetricians and Gynecologists (ACOG), a major advocacy group of women's heatlth care physicians, quietly replaced Patient Handout #156, entitled “How Your Baby Grows During Pregnancy,” with a new version replacing the word “baby” with “fetus.”  The new September 2017 version, “How Your Fetus Grows During Pregnancy” replaces the June 2015 edition, with essentially no other major changes.

It is thought that most OB/GYN's did not notice the change as it was not announced or publicized in the organization's journal.  The change came to the attention of most Obstetricians only after a November 22nd  email was sent out announcing all of the new resources available, with the newly titled handout included in the list.  The handout is meant to be distributed to patients at their first Obstetrical visits, and is part of a collection of handouts published by ACOG for patient counseling.   

“It makes a really big difference.”  said Dr. Greg Marchand, a board certified OBGYN.  “There's some really big political implications here.  We are talking about the difference between telling a newly pregnant mom that she is pregnant with a baby or pregnant with a fetus.  This is early in pregnancy, when pregnancy termination is still something many new moms are considering.”

Although Dr. Marchand stated that the new handout doesn't contain any new recommendations or changes in the care that Obstetricians give, it speaks volumes to the expectations of the Obstetrician in early pregnancy care.  He stated this could be offensive to many physicians opposed to abortion, by forcing the term “fetus” into a discussion that otherwise might not contain much awareness of the availability of termination in the first trimester.

To learn more about Dr. Marchand's research, publications and surgery you can visit www.GregMarchandMD.com

Media Contact
Contact Person: Maria Sainz
Phone: 480-695-5211
Country: United States
Website: www.gregmarchandmd.com



Detailed Study on Point of Care Technology Market | Which is Expected to Reach at a CAGR of 9.5% by 2023


"Point of Care Technology Market"
Market Research Future has a half cooked research report on the global point of care technology market. Point of Care Technology Market is Expected to Grow at a CAGR of 9.5% by 2023

Point of care technology is termed as a time when clinicians deliver healthcare products and services to patients. Point of care technology includes diagnostics, devices for documentation, and others. Point of care documentation devices smooth the workflow, reduces errors in a clinical tasks including diagnostics, medication prescribing, and medication administration, which will indirectly boost the growth of the market. Moreover, increasing prevalence of the diseases and rising research and development facilities. Furthermore, rising healthcare expenditure, and increasing awareness among the people regarding the point of care diagnostics products, are some of the factors that are expected to fuel the market growth. On the other hand, higher cost of the point of care technology is may affect the growth of the market negatively during the forecasted period. Moreover, development in the diagnosis of patients with chronic diseases, for instance, diabetes, and growing medical technology are likely to increase the growth of the market. In point of care technology, it provides ease of diagnosis where the patient is seen at home. The point of care testing devices in the healthcare focuses on quality rather than test volume, which is expected to boost the growth of the market over the review period.

Complexity of documentation in the point of care technology may hinder the growth of the market during the forecasted period.

The global point of care technology market is expected to grow at a CAGR of 9.5% during the forecast period 2017-2023.

Taste the market data and market information presented through more than 105 market data tables and figures spread over 100 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “point of care technology market research report–Global forecast till 2023.”

 Sample Report Available at https://www.marketresearchfuture.com/sample_request/1164 .

Major Players in Point of care technology Market

Some of the key players in the global market are Abbott (U.S.), Johnson & Johnson Services, Inc.(U.S.), Techno MedicaCo., Ltd. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Beckman Coulter, Inc. (U.S.) BD (U.S.), Quidel Corporation (U.S), Meridian Bioscience, Inc. (U.S).

Regional Analysis

The global point of care technology market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas accounts for a significant share of the global point of care technology market as a result of the presence of huge & increasing patient population base and the largest producer and consumer of medical devices. Similarly, the demand for medical devices in Europe is expected to increase growth of the market positively. Europe holds the second position in the global market, which is followed by Asia Pacific. Asia Pacific may experience the growth owing to the presence of abundant opportunities for medical device manufacturers. For instance, healthcare services revenue is increasing rapidly, especially, in India and China, which is predicated to result in a large number of new hospital construction projects.

Whereas, the Middle East & Africa holds the least share in the global point of care technology market on account of poor economic condition and less development in healthcare infrastructure.

Segmentation

The global point of care technology is segmented by type of products, and end users. On the basis of type of product, it is segmented into glucose testing, cardiac markers, HbA1c testing, and coagulation, and others. On the basis of end users, it is segmented into clinics, hospital, home care, ambulatory care, and others.

 Browse complete report at https://www.marketresearchfuture.com/reports/point-of-care-technology-market-1164 . 

Point-of-care testing allows patient diagnosis, in an ambulance, the home, the field, or in the hospital. The results of care are timely, and allow rapid treatment to the patient. Point of care technology market is growing rapidly due to the evolving healthcare industry, especially in developing nations. The major factors that propel the growth of the market are development in diagnostics, patients with chronic diseases, increasing growth in medical technology, and other uses of point of care technology. Moreover, increasing investment in research and development among the developed countries will also boost the growth of the market positively during the forecast period. Furthermore, advancement of diagnostic laboratories and adoption of automated lab systems, is likely to fuel the growth of the market. On the other hand, complexity of documentation and investment cost involved in this type of care technology, may hinder the growth of the market during the forecasted period. 

Table Of Contents

1    Report Prologue    

2    Market Introduction    


      2.1    Introduction    

      2.2    Scope Of Study    

      2.3    Research Objective    

      2.4    Assumptions & Limitations    

            2.4.1    Assumptions    

            2.4.2    Limitations    

3    Research Methodology    

      3.1    Research Process    

      3.2    Primary Research    

      3.3    Secondary Research    

4    Market Dynamics    

      4.1    Drivers    

      4.2    Restraints    

 

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/point-of-care-technology-market-1164



Detailed Study on Point of Care Technology Market | Which is Expected to Reach at a CAGR of 9.5% by 2023


"Point of Care Technology Market"
Market Research Future has a half cooked research report on the global point of care technology market. Point of Care Technology Market is Expected to Grow at a CAGR of 9.5% by 2023

Point of care technology is termed as a time when clinicians deliver healthcare products and services to patients. Point of care technology includes diagnostics, devices for documentation, and others. Point of care documentation devices smooth the workflow, reduces errors in a clinical tasks including diagnostics, medication prescribing, and medication administration, which will indirectly boost the growth of the market. Moreover, increasing prevalence of the diseases and rising research and development facilities. Furthermore, rising healthcare expenditure, and increasing awareness among the people regarding the point of care diagnostics products, are some of the factors that are expected to fuel the market growth. On the other hand, higher cost of the point of care technology is may affect the growth of the market negatively during the forecasted period. Moreover, development in the diagnosis of patients with chronic diseases, for instance, diabetes, and growing medical technology are likely to increase the growth of the market. In point of care technology, it provides ease of diagnosis where the patient is seen at home. The point of care testing devices in the healthcare focuses on quality rather than test volume, which is expected to boost the growth of the market over the review period.

Complexity of documentation in the point of care technology may hinder the growth of the market during the forecasted period.

The global point of care technology market is expected to grow at a CAGR of 9.5% during the forecast period 2017-2023.

Taste the market data and market information presented through more than 105 market data tables and figures spread over 100 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “point of care technology market research report–Global forecast till 2023.”

 Sample Report Available at https://www.marketresearchfuture.com/sample_request/1164 .

Major Players in Point of care technology Market

Some of the key players in the global market are Abbott (U.S.), Johnson & Johnson Services, Inc.(U.S.), Techno MedicaCo., Ltd. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Beckman Coulter, Inc. (U.S.) BD (U.S.), Quidel Corporation (U.S), Meridian Bioscience, Inc. (U.S).

Regional Analysis

The global point of care technology market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas accounts for a significant share of the global point of care technology market as a result of the presence of huge & increasing patient population base and the largest producer and consumer of medical devices. Similarly, the demand for medical devices in Europe is expected to increase growth of the market positively. Europe holds the second position in the global market, which is followed by Asia Pacific. Asia Pacific may experience the growth owing to the presence of abundant opportunities for medical device manufacturers. For instance, healthcare services revenue is increasing rapidly, especially, in India and China, which is predicated to result in a large number of new hospital construction projects.

Whereas, the Middle East & Africa holds the least share in the global point of care technology market on account of poor economic condition and less development in healthcare infrastructure.

Segmentation

The global point of care technology is segmented by type of products, and end users. On the basis of type of product, it is segmented into glucose testing, cardiac markers, HbA1c testing, and coagulation, and others. On the basis of end users, it is segmented into clinics, hospital, home care, ambulatory care, and others.

 Browse complete report at https://www.marketresearchfuture.com/reports/point-of-care-technology-market-1164 . 

Point-of-care testing allows patient diagnosis, in an ambulance, the home, the field, or in the hospital. The results of care are timely, and allow rapid treatment to the patient. Point of care technology market is growing rapidly due to the evolving healthcare industry, especially in developing nations. The major factors that propel the growth of the market are development in diagnostics, patients with chronic diseases, increasing growth in medical technology, and other uses of point of care technology. Moreover, increasing investment in research and development among the developed countries will also boost the growth of the market positively during the forecast period. Furthermore, advancement of diagnostic laboratories and adoption of automated lab systems, is likely to fuel the growth of the market. On the other hand, complexity of documentation and investment cost involved in this type of care technology, may hinder the growth of the market during the forecasted period. 

Table Of Contents

1    Report Prologue    

2    Market Introduction    


      2.1    Introduction    

      2.2    Scope Of Study    

      2.3    Research Objective    

      2.4    Assumptions & Limitations    

            2.4.1    Assumptions    

            2.4.2    Limitations    

3    Research Methodology    

      3.1    Research Process    

      3.2    Primary Research    

      3.3    Secondary Research    

4    Market Dynamics    

      4.1    Drivers    

      4.2    Restraints    

 

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/point-of-care-technology-market-1164



Future Trends Medical Suction Devices Market | World Major Key Players | Which is Expected to Grow at a Steady CAGR Of 4.5% Forecast to 2023


"rnMedical Suction Device Market"
Market Research Future published a half-cooked research report on global medical suction device market. Medical Suction Device Market is Expected to Grow at a CAGR of ~ 4.5% by 2023

Medical suction devices Market clear the airway blocked by mucus or other secretions, which ease the breathing issue with the patient. The global medical suction device market will grow significantly during the review period. Currently, the global medical suction devices market is undergoing a rapid change due to the technological developments. The medical suction machines are used for the dental, baby delivery, respiratory and many more. Rising number of patients with respiratory diseases, developing technology, and rising geriatric population, the market is experiencing a rapid growth. Furthermore, increasing birth rates and increasing demand for the different respiratory devices boost the demand for medical suction device. Conversely, poor reimbursement policies for the medical devices may restrained the growth of the market over the corresponding period.

The global medical suction device market is expected grow at a steady CAGR of 4.5% during the forecasted period.  

Sample Report Available at https://www.marketresearchfuture.com/sample_request/546 .

Key Players

Some of the key players in the global medical suction device market are ATMOS MedizinTechnik GmbH & Co. KG (Germany), Allied Healthcare (UK), Drive Medical (US), INTEGRA Biosciences AG (Switzerland), Precision Medical, Inc. (US), Siemens Healthcare Private Limited (Germany), Olympus Corporation (Japan), Medico, Inc. (US), SSCOR, Inc. (US), ZOLL Medical Corporation (US), Labconco (US), Amsino International, Inc. (US), Welch Vacuum (US), and Laerdal Medical (Norway) 

The global market of medical suction device market is segmented on the basis of types, applications, suction parts, and end users.

On the basis of types, the market is segmented into electric powered, battery-powered, dual, manual, and others.

On the basis of applications, the market is segmented into surgical, research, and other. The surgical applications are further segmented into respiratory diseases, childbirth, and others.

On the basis of suction parts, it is segmented into vacuum pump, bacterial filter, vacuum gauge, moisture or debris trap, suction catheter, and others.

On the basis of end users, the market is segmented into homecare, hospital, clinics, and others. 

Regional Analysis

The America dominates the global medical suction devices market, which is followed by Europe. The Americas medical suction device market growth is attributed to increasing number of patients with respiratory diseases, large geriatric population, high healthcare spending, and well-developed healthcare sector.

The European medical suction device market is growing due to increasing government support to research & development, high healthcare expenditure, and increasing birth rate. According to the OECD, the healthcare expenditure in Germany was EUR 321 billion in 2014, which is followed by France with healthcare expenditure of EUR 237 billion. According to the Eurostat, in 2015, the average birth rate in Europe was 1.6 children per woman.  Asia Pacific market shows the fastest growth owing to the presence of the huge patient population and rapidly developing economies. However, the Middle East & Africa region holds the least market share with a steady growth due to limited healthcare spending and less development in the medical sector.

The global medical suction devices market is highly fragmented with the presence of many local and international players. As a result, local players are focusing on cost reduction and innovation to ensure sustainability in the market. On the other hand, the international players are focusing on collaborations and partnerships to expand their global market share.

Drive Medicals, headquartered in the US, is a world leader in the designing, manufacturing, and marketing of respiratory medical products. In 2014, the company acquired Medquip, a manufacturer of high-quality and innovative healthcare products. Additionally, in 2015, Drive Medical acquired DeVilbiss, a global manufacturer of respiratory and sleep products and now known as Drive DeVilbiss Healthcare, Inc.

 Browse complete report at https://www.marketresearchfuture.com/reports/medical-suction-device-market-546 . 

The Americas holds the largest share of the global medical suction device market owing to the presence of huge number of patient with respiratory diseases, increasing geriatric population, and increasing healthcare expenditure. Europe is the second largest market followed by Asia Pacific due to increasing government support and changing reimbursement policies in Europe. The Asia Pacific region is the fastest growing market owing to the presence of huge patient population, increasing prevalence of the respiratory diseases, high birth rate, and the presence of rapidly developing economies. On the other hand, the Middle East & Africa is expected to have a limited but steady growth over the forecasted period.

 

Table Of Contents

1    Report Prologue    

2    Market Introduction   
 

      2.1    Introduction    

      2.2    Scope Of Study    

      2.3    Research Objective    

      2.4    Assumptions & Limitations    

            2.4.1    Assumptions    

            2.4.2    Limitations    

3    Research Methodology    

      3.1    Research Process    

      3.2    Primary Research    

      3.3    Secondary Research    

4    Market Dynamics    

      4.1    Drivers    

      4.2    Restraints    

5    Market Factor Analysis    

      5.1    Porter’s Five Forces Model    

            5.1.1    Bargaining Power Of Suppliers    

            5.1.2    Bargaining Power Of Buyers    

            5.1.3    Threat Of New Entrants    

            5.1.4    Threat Of Substitutes    

            5.1.5    Intensity Of Rivalry    

      5.2    Supply Chain Analysis    

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/medical-suction-device-market-546



The World Carcinoembryonic Antigen Market is Projected to Reach at a CAGR of 6.7% by 2023


"rnCarcinoembryonic Antigen Market"
Market Research Future publishes a half cooked research report on the Global Carcinoembryogenic Antigen Market, Which is Projected to Reach at a CAGR of 6.7% by 2023

Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician.

In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the market growth.

Increasing prevalence of cancer, rising healthcare expenditures, and developing diagnostic technologies will boost the global market during the forecast period. However, risk of infection and hematoma, lack of awareness and medical services in the developing countries will restrain the market growth during the assessment period.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Carcinoembryogenic Antigen Market” Research Report – Forecast till 2023. 

Get a sample copy of this report at https://www.marketresearchfuture.com/sample_request/772 . 

Market Players

Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.

Regional Analysis

The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period.

Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period.

On account of the developing medical infrastructure, rising healthcare expenditure, and increasing government initiatives, Asia Pacific region is expected to grow the fastest.

The Middle East & Africa is expected to grow slower than the global average. The Middle Eastern countries, for instance, UAE and Saudi Arabia dominates the market due to high income and the government support to improve public health. 

Complete Report Available at https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772 .

The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.

Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others.  

Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.

Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.

The report Global Carcinoembryogenic Antigen Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772